nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Application of Preclinical Data to Initiate the Modified Continual Reassessment Method for Maximum Tolerated Dose–Finding Trials
|
Mahmood, Iftekhar |
|
2001 |
41 |
1 |
p. 19-24 |
artikel |
2 |
Can [15O]Water Be Used to Evaluate Drugs?
|
Herscovitch, Peter |
|
2001 |
41 |
1 |
p. 11s-20s |
artikel |
3 |
Effect of Fluoxetine on Carvedilol Pharmacokinetics, CYP2D6 Activity, and Autonomic Balance in Heart Failure Patients
|
Graff, Donald W. |
|
2001 |
41 |
1 |
p. 97-106 |
artikel |
4 |
Effect of Rofecoxib on the Pharmacokinetics of Digoxin in Healthy Volunteers
|
Schwartz, Jules I. |
|
2001 |
41 |
1 |
p. 107-112 |
artikel |
5 |
Errata
|
|
|
2001 |
41 |
1 |
p. 116-116 |
artikel |
6 |
Evaluation of CYP2D6 Oxidation of Dextromethorphan and Propafenone in a Chinese Population with Atrial Fibrillation
|
Chow, Moses S. S. |
|
2001 |
41 |
1 |
p. 92-96 |
artikel |
7 |
18FDG for the Study of Central Nervous System Drugs
|
Fowler, Joanna S. |
|
2001 |
41 |
1 |
p. 9s-10s |
artikel |
8 |
Imaging Cellular Proliferation as a Measure of Response to Therapy
|
Krohn, Kenneth A. |
|
2001 |
41 |
1 |
p. 96s-103s |
artikel |
9 |
Immunological and Molecular Analysis of the Sentinel Lymph Node: A Potential Approach to Predict Outcome, Tailor Therapy, and Optimize Parameters for Tumor Vaccine Development
|
Meijer, S. L. |
|
2001 |
41 |
1 |
p. 81s-94s |
artikel |
10 |
Inhibition of Human Cytochrome P450 Isoforms by Nonnucleoside Reverse Transcriptase Inhibitors
|
von Moltke, Lisa L. |
|
2001 |
41 |
1 |
p. 85-91 |
artikel |
11 |
In Vitro and in Vivo Techniques Used in Drug Development for Evaluation of Dose Delivery of Inhaled Corticosteroids
|
Rhodes, Gerald R. |
|
2001 |
41 |
1 |
p. 7-18 |
artikel |
12 |
Licensing and Distribution of Research Tools: National Institutes of Health Perspective
|
Ferguson, Steven M. |
|
2001 |
41 |
1 |
p. 110s-112s |
artikel |
13 |
Measurement of Tumor Response Using [18F]-2-Fluoro-2-Deoxy-D-Glucose and Positron-Emission Tomography
|
Lammertsma, Adriaan A. |
|
2001 |
41 |
1 |
p. 104s-106s |
artikel |
14 |
Monitoring Disease Progression in Parkinson's Disease
|
Doudet, Doris J. |
|
2001 |
41 |
1 |
p. 72s-80s |
artikel |
15 |
99mTc-Tetrofosmin for Functional Imaging of P-glycoprotein Modulation In Vivo
|
Ballinger, James R. |
|
2001 |
41 |
1 |
p. 39s-47s |
artikel |
16 |
Neuroimaging and Drug Development: An Algorithm for Decision Making
|
Kapur, Shitij |
|
2001 |
41 |
1 |
p. 64s-71s |
artikel |
17 |
Neuroimaging Consortium Workshop: Development of Novel PET and SPECT Ligands for Brain Imaging
|
Brady, Linda |
|
2001 |
41 |
1 |
p. 116s-117s |
artikel |
18 |
Nonimaging Detectors in Drug Development and Approval
|
Wagner, Henry N. |
|
2001 |
41 |
1 |
p. 125s-126s |
artikel |
19 |
Nuclear Imaging and Biomarkers in Drug Development Using Approved Radiopharmaceuticals
|
Eckelman, William C. |
|
2001 |
41 |
1 |
p. 4s-6s |
artikel |
20 |
P-glycoprotein at the Blood-Brain Barrier and Analysis of Drug Transport with Positron-Emission Tomography
|
Hendrikse, N. H. |
|
2001 |
41 |
1 |
p. 48s-54s |
artikel |
21 |
Pharmacokinetic-Pharmacodynamic Modeling of Atracurium in Intensive Care Patients
|
Farenc, Christine |
|
2001 |
41 |
1 |
p. 44-50 |
artikel |
22 |
Pharmacokinetic-Pharmacodynamic Modeling of the Antilipolytic Effects of an Adenosine Receptor Agonist in Healthy Volunteers
|
Zannikos, Peter N. |
|
2001 |
41 |
1 |
p. 61-69 |
artikel |
23 |
Pharmacokinetic-Pharmacodynamic Modeling of the Electroencephalogram Effects of Scopolamine in Healthy Volunteers
|
Ebert, Ulrike |
|
2001 |
41 |
1 |
p. 51-60 |
artikel |
24 |
Pharmacokinetics of Tilidine in Terminal Renal Failure
|
Seiler, K. -U. |
|
2001 |
41 |
1 |
p. 79-84 |
artikel |
25 |
Positron-Emission Tomography Tracers as Intellectual Property
|
Innis, R. |
|
2001 |
41 |
1 |
p. 107s-107s |
artikel |
26 |
Prospects for Human Pharmacological Functional Magnetic Resonance Imaging (phMRI)
|
Tracey, Irene |
|
2001 |
41 |
1 |
p. 21s-28s |
artikel |
27 |
Reduction of LDL Cholesterol in Patients with Primary Hypercholesterolemia by SCH 48461: Results of a Multicenter Dose-Ranging Study
|
Dujovne, Carlos A. |
|
2001 |
41 |
1 |
p. 70-78 |
artikel |
28 |
Regulation of the Production and Use of Radiopharmaceuticals in Germany and Europe
|
Kuwert, Torsten |
|
2001 |
41 |
1 |
p. 121s-122s |
artikel |
29 |
Regulatory Aspects of Nuclear Imaging in Neuropharmacology
|
Katz, Russell |
|
2001 |
41 |
1 |
p. 122s-124s |
artikel |
30 |
Reversal of Multidrug Resistance with LY335979: Functional Analysis of P-glycoprotein-Mediated Transport Activity and Its Modulation In Vivo
|
Slapak, Christopher A. |
|
2001 |
41 |
1 |
p. 29s-38s |
artikel |
31 |
Serotonin 5-HT1A Receptor Imaging in the Human Brain with Positron-Emission Tomography: Coordination and the Standardization and Dissemination of Methodology
|
Halldin, Christer |
|
2001 |
41 |
1 |
p. 95s-95s |
artikel |
32 |
Single-Dose Pharmacokinetics of Sotalol in a Pediatric Population with Supraventricular and/or Ventricular Tachyarrhythmia
|
Saul, Philip J. |
|
2001 |
41 |
1 |
p. 35-43 |
artikel |
33 |
Submission of Images to the Center for Biologics Evaluation and Research in Support of License Applications for Therapeutic Agents
|
Fauntleroy, Michael |
|
2001 |
41 |
1 |
p. 119s-121s |
artikel |
34 |
The 2000 Alfred P. Wolf Award
|
Burns, Donald |
|
2001 |
41 |
1 |
p. 7s-8s |
artikel |
35 |
The Molecular Imaging Branch of NIMH: PET and SPECT Tracers
|
Innis, Robert |
|
2001 |
41 |
1 |
p. 108s-109s |
artikel |
36 |
The Patenting of Tools for Drug Discovery and Development
|
Esmond, Robert W. |
|
2001 |
41 |
1 |
p. 112s-115s |
artikel |
37 |
The Process of Knowledge Discovery from Large Pharmacokinetic Data Sets
|
Ette, Ene I. |
|
2001 |
41 |
1 |
p. 25-34 |
artikel |
38 |
The Tolerability of Newer Immunosuppressive Medications in a Patient with Acute Intermittent Porphyria
|
Barone, Gary W. |
|
2001 |
41 |
1 |
p. 113-115 |
artikel |
39 |
The Use of Imaging as Biomarkers in Drug Development: Regulatory Issues Worldwide
|
Katz, R. |
|
2001 |
41 |
1 |
p. 118s-118s |
artikel |
40 |
The Use of MicroPET for the Development of Neural Repair Therapeutics: Studies in Epilepsy and Lesion Models
|
Kornblum, Harley I. |
|
2001 |
41 |
1 |
p. 55s-63s |
artikel |